World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
131
Citations
67856
World Ranking
2386
National Ranking
250

Research.com Recognitions

  • 2016 - Member of Academia Europaea
  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom

Overview

Munir Pirmohamed is affiliated with the University of Liverpool in the United Kingdom. Their body of work focuses primarily on medicine, with significant contributions to pharmacology, oncology, genetics, molecular biology, and infectious diseases.

Their research topics cover a range of areas including pharmacogenetics and drug metabolism, drug-induced adverse reactions, pharmacovigilance and adverse drug reactions, pharmaceutical studies and practices, health systems, economic evaluations and quality of life, computational drug discovery methods, and pharmaceutical practices and patient outcomes.

Notable recent publications by Munir Pirmohamed include:

  • Pharmacogenomics: current status and future perspectives (2023) published in Nature Reviews Genetics
  • A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study (2023) published in The Lancet
  • Identifying and visualising multimorbidity and comorbidity patterns in patients in the English National Health Service: a population-based study (2022) published in The Lancet Digital Health
  • Adverse drug reactions, multimorbidity and polypharmacy: a prospective analysis of 1 month of medical admissions (2022) published in BMJ Open
  • A Review of the Important Role of CYP2D6 in Pharmacogenomics (2020) published in Genes

Frequent co-authors working with Munir Pirmohamed include Andrea Jorgensen, Richard M. Turner, Dean J. Naisbitt, Innocent G. Asiimwe, and Daniel F. Carr.

The scientist has published extensively in specific journals such as:

  • British Journal of Clinical Pharmacology (15 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (11 publications)
  • Clinical Pharmacology & Therapeutics (9 publications)
  • Pathology (8 publications)
  • BMJ Open (6 publications)

Munir Pirmohamed has been recognized through membership and fellowship awards including Member of Academia Europaea in 2016 and Fellowship of The Academy of Medical Sciences, United Kingdom.

Best Publications

  • Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients

    Munir Pirmohamed;Sally James;Shaun Meakin;Chris Green

  • Drug repurposing: progress, challenges and recommendations

    Sudeep Pushpakom;Francesco Iorio;Patrick A Eyers;K Jane Escott

  • Phase I Clinical Trial of Oral Curcumin: Biomarkers of Systemic Activity and Compliance

    Ricky A. Sharma;Stephanie A. Euden;Sharon L. Platton;Darren N. Cooke

  • HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.

    Ann K Daly;Peter T Donaldson;Pallav Bhatnagar;Yufeng Shen

  • Pharmacodynamic and Pharmacokinetic Study of Oral Curcuma Extract in Patients with Colorectal Cancer

    Ricky A. Sharma;Heather R. McLelland;Kirsti A. Hill;Christopher R. Ireson

  • HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans

    Mark McCormack;Ana Alfirevic;Stephane Bourgeois;John J. Farrell

  • A Randomized Trial of Genotype-Guided Dosing of Warfarin

    Munir Pirmohamed;Girvan Burnside;Niclas Eriksson;Andrea L. Jorgensen

  • Adverse Drug Reactions in Hospital In-Patients: A Prospective Analysis of 3695 Patient-Episodes

    Emma C. Davies;Christopher F. Green;Stephen Taylor;Paula R. Williamson

  • Emergence and global spread of epidemic healthcare-associated Clostridium difficile.

    Miao He;Fabio Miyajima;Paul Roberts;Louise Ellison

  • Active Transport of Imatinib into and Out of Cells: Implications for Drug Resistance

    Julia Thomas;Lihui Wang;Richard E. Clark;Munir Pirmohamed

  • Which drugs cause preventable admissions to hospital? A systematic review

    R. L. Howard;A. J. Avery;S. Slavenburg;S. Royal

  • Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing

    J. A. Johnson;L. Gong;M. Whirl-Carrillo;B. F. Gage

  • Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update.

    JA Johnson;KE Caudle;L Gong;M Whirl-Carrillo

  • THE ROLE OF METABOLIC ACTIVATION IN DRUG-INDUCED HEPATOTOXICITY

    B. Kevin Park;Neil R. Kitteringham;James L. Maggs;Munir Pirmohamed

  • Fortnightly review: Adverse drug reactions

    Munir Pirmohamed;Alasdair M Breckenridge;Neil R Kitteringham;B Kevin Park

  • Susceptibility to Amoxicillin-Clavulanate-Induced Liver Injury is Influenced by Multiple HLA Class I and II Alleles

    M. Isabel Lucena;Mariam Molokhia;Yufeng Shen;Thomas J. Urban

  • Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology.

    Thomas Eschenhagen;Thomas Force;Michael S. Ewer;Gilles W. De Keulenaer

  • How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines

    H. G. Laverty;C. Benson;E. J. Cartwright;M. J. Cross

  • Pharmacogenetics of warfarin: current status and future challenges

    Mia Wadelius;Munir Pirmohamed

  • Genetic susceptibility to adverse drug reactions.

    Munir Pirmohamed;B.Kevin Park

Frequent Co-Authors

B. Kevin Park
B. Kevin Park University of Liverpool
Dean J. Naisbitt
Dean J. Naisbitt University of Liverpool
Ann K. Daly
Ann K. Daly Newcastle University
Paula R Williamson
Paula R Williamson University of Liverpool
Anthony G Marson
Anthony G Marson University of Liverpool
Saye Khoo
Saye Khoo University of Liverpool
Guruprasad P. Aithal
Guruprasad P. Aithal University of Nottingham
James L. Maggs
James L. Maggs University of Liverpool
Liam Smeeth
Liam Smeeth London School of Hygiene & Tropical Medicine
Jackie Cassell
Jackie Cassell Brighton and Sussex Medical School

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine opens up numerous alternative educational routes and related healthcare professions. Online programs have made it easier than ever to develop expertise while maintaining flexibility. For those interested in leadership, an accelerated healthcare administration degree can fast-track your path to management roles in hospitals or clinics.

Nurses aiming to become Family Nurse Practitioners should consider the asn to fnp bridge pathway, which allows ADN-trained nurses to earn a Master’s degree and advance their clinical practice. If you have a passion for prevention and wellness, a nutrition degree online can lead to careers in dietetics, health education, or public health.

Aspiring healthcare executives will benefit from enrolling in one of the best mha programs that are CAHME-accredited and offered online for maximum convenience. Research your options to find the online degree that best matches your career goals and preferred healthcare pathway.

Best Scientists Citing Munir Pirmohamed

Trending Scientists

Recently Published Articles